221 related articles for article (PubMed ID: 30373803)
21. Chemoprophylactic effects of azithromycin against Rhodococcus equi-induced pneumonia among foals at equine breeding farms with endemic infections.
Chaffin MK; Cohen ND; Martens RJ
J Am Vet Med Assoc; 2008 Apr; 232(7):1035-47. PubMed ID: 18380623
[TBL] [Abstract][Full Text] [Related]
22. Association of soil concentrations of Rhodococcus equi and incidence of pneumonia attributable to Rhodococcus equi in foals on farms in central Kentucky.
Cohen ND; Carter CN; Scott HM; Chaffin MK; Smith JL; Grimm MB; Kuskie KR; Takai S; Martens RJ
Am J Vet Res; 2008 Mar; 69(3):385-95. PubMed ID: 18312138
[TBL] [Abstract][Full Text] [Related]
23. Acquired antimicrobial resistance in equine Rhodococcus equi isolates.
Boyen F; Pasmans F; Haesebrouck F
Vet Rec; 2011 Jan; 168(4):101a. PubMed ID: 21257598
[No Abstract] [Full Text] [Related]
24. Gallium maltolate as an alternative to macrolides for treatment of presumed Rhodococcus equi pneumonia in foals.
Cohen ND; Slovis NM; Giguère S; Baker S; Chaffin MK; Bernstein LR
J Vet Intern Med; 2015; 29(3):932-9. PubMed ID: 25868480
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi.
Berghaus LJ; Giguère S; Guldbech K; Warner E; Ugorji U; Berghaus RD
J Clin Microbiol; 2015 Jan; 53(1):314-8. PubMed ID: 25378571
[TBL] [Abstract][Full Text] [Related]
26. [Diagnosis and therapy of Rhodococcus equi infection in the horse].
Boswinkel M; Sloet van Oldruitenborgh-Oosterbaan MM
Tijdschr Diergeneeskd; 2006 Sep; 131(17):602-11. PubMed ID: 16989420
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of liposomal gentamicin against Rhodococcus equi in a mouse infection model and colocalization with R. equi in equine alveolar macrophages.
Burton AJ; Giguère S; Berghaus LJ; Hondalus MK; Arnold RD
Vet Microbiol; 2015 Apr; 176(3-4):292-300. PubMed ID: 25666452
[TBL] [Abstract][Full Text] [Related]
28. Distribution and antimicrobial susceptibility of Rhodococcus equi from clinical specimens.
McNeil MM; Brown JM
Eur J Epidemiol; 1992 May; 8(3):437-43. PubMed ID: 1397208
[TBL] [Abstract][Full Text] [Related]
29. Fitness cost conferred by the novel erm(51) and rpoB mutation on environmental multidrug resistant-Rhodococcus equi.
Rivera-Velez A; Huber L; Sinha S; Cohen ND
Vet Microbiol; 2022 Oct; 273():109531. PubMed ID: 35944389
[TBL] [Abstract][Full Text] [Related]
30. Novel transferable erm(46) determinant responsible for emerging macrolide resistance in Rhodococcus equi.
Anastasi E; Giguère S; Berghaus LJ; Hondalus MK; Willingham-Lane JM; MacArthur I; Cohen ND; Roberts MC; Vazquez-Boland JA
J Antimicrob Chemother; 2015 Dec; 70(12):3184-90. PubMed ID: 26377866
[TBL] [Abstract][Full Text] [Related]
31. Association of disease with isolation and virulence of Rhodococcus equi from farm soil and foals with pneumonia.
Martens RJ; Takai S; Cohen ND; Chaffin MK; Liu H; Sakurai K; Sugimoto H; Lingsweiler SW
J Am Vet Med Assoc; 2000 Jul; 217(2):220-5. PubMed ID: 10909463
[TBL] [Abstract][Full Text] [Related]
32. Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility.
Mascellino MT; Iona E; Ponzo R; Mastroianni CM; Delia S
Int J Clin Pharmacol Res; 1994; 14(5-6):157-63. PubMed ID: 7672872
[TBL] [Abstract][Full Text] [Related]
33. International Spread of Multidrug-Resistant Rhodococcus equi.
Val-Calvo J; Darcy J; Gibbons J; Creighton A; Egan C; Buckley T; Schmalenberger A; Fogarty U; Scortti M; Vázquez-Boland JA
Emerg Infect Dis; 2022 Sep; 28(9):1899-1903. PubMed ID: 35997496
[TBL] [Abstract][Full Text] [Related]
34. A Common Practice of Widespread Antimicrobial Use in Horse Production Promotes Multi-Drug Resistance.
Álvarez-Narváez S; Berghaus LJ; Morris ERA; Willingham-Lane JM; Slovis NM; Giguere S; Cohen ND
Sci Rep; 2020 Jan; 10(1):911. PubMed ID: 31969575
[TBL] [Abstract][Full Text] [Related]
35. Disposition of oral clarithromycin in foals.
Jacks S; Giguère S; Gronwall RR; Brown MP; Merritt KA
J Vet Pharmacol Ther; 2002 Oct; 25(5):359-62. PubMed ID: 12423226
[TBL] [Abstract][Full Text] [Related]
36. Activity of 10 antimicrobial agents against intracellular Rhodococcus equi.
Giguère S; Berghaus LJ; Lee EA
Vet Microbiol; 2015 Aug; 178(3-4):275-8. PubMed ID: 26051479
[TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials.
Jacks SS; Giguère S; Nguyen A
Antimicrob Agents Chemother; 2003 May; 47(5):1742-5. PubMed ID: 12709351
[TBL] [Abstract][Full Text] [Related]
38. Clonal Confinement of a Highly Mobile Resistance Element Driven by Combination Therapy in Rhodococcus equi.
Álvarez-Narváez S; Giguère S; Anastasi E; Hearn J; Scortti M; Vázquez-Boland JA
mBio; 2019 Oct; 10(5):. PubMed ID: 31615959
[TBL] [Abstract][Full Text] [Related]
39. Emergence of rifampin-resistant Rhodococcus equi with several types of mutations in the rpoB gene among AIDS patients in northern Thailand.
Asoh N; Watanabe H; Fines-Guyon M; Watanabe K; Oishi K; Kositsakulchai W; Sanchai T; Kunsuikmengrai K; Kahintapong S; Khantawa B; Tharavichitkul P; Sirisanthana T; Nagatake T
J Clin Microbiol; 2003 Jun; 41(6):2337-40. PubMed ID: 12791846
[TBL] [Abstract][Full Text] [Related]
40. Spread of Multidrug-Resistant Rhodococcus equi, United States.
Álvarez-Narváez S; Giguère S; Cohen N; Slovis N; Vázquez-Boland JA
Emerg Infect Dis; 2021 Feb; 27(2):529-537. PubMed ID: 33496218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
